Fix Your Funds

Investing in the stock market is a dynamic journey, with some shares weathering tough times but eventually revealing green shoots of a turnaround. In the realm of the S&P/ASX 200 Index (ASX: XJO), catching positive momentum early can be a rewarding strategy. This article explores the insights of Fairmont Equities managing director Michael Gable, who identifies two ASX 200 stocks, Resmed CDI (ASX: RMD) and BHP Group Ltd ( ASX: BHP ), as potential buys. Image Credit: Pexels Resmed CDI (ASX: RMD) - Navigating Challenges The narrative surrounding Resmed CDI shares has been challenging this year. The emergence of new GLP-1 weight loss drugs, such as Ozempic, has created concerns among investors. The fear is that a reduction in obesity could lead to fewer opportunities for a sleep apnea device maker like ResMed. Consequently, the ASX 200 stock experienced a 26.5% decline since early August. However, there's a glimmer of hope with a 15.5% revival over the past seven weeks. Gable, opt...